{"id":62750,"date":"2026-03-06T16:06:37","date_gmt":"2026-03-06T15:06:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/"},"modified":"2026-03-06T16:06:37","modified_gmt":"2026-03-06T15:06:37","slug":"viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/","title":{"rendered":"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America"},"content":{"rendered":"<div>\n<p>PALM BEACH GARDENS, Fla.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/ClinicalExcellence?src=hash\" target=\"_blank\">#ClinicalExcellence<\/a>&#8211;Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vascspecialists.org%2F&amp;esheet=54439715&amp;newsitemid=20260306796574&amp;lan=en-US&amp;anchor=Vascular+Specialists&amp;index=1&amp;md5=1016601cbb9327eb4612d9188df41954\" rel=\"nofollow\" shape=\"rect\"><b>Vascular Specialists<\/b><\/a> in its strategic partnership with <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcuc-us.com%2F&amp;esheet=54439715&amp;newsitemid=20260306796574&amp;lan=en-US&amp;anchor=CUC+America&amp;index=2&amp;md5=96079c38292a77f3a8e331e3cd1fb311\" rel=\"nofollow\" shape=\"rect\"><b>CUC America<\/b><\/a>, a leading healthcare services organization focused on supporting physician-led specialty platforms.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/5\/VP_Logo_White.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/5\/VP_Logo_White.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/21\/VP_Logo_White.jpg\"><\/a><\/p>\n<p>\nVascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis and treatment for patients with vascular disease. The practice has built a strong reputation for clinical excellence, advanced treatment capabilities, and patient-centered care across the markets it serves. Through its experienced team of physicians and clinical staff, the organization provides a full range of vascular services including minimally invasive procedures, diagnostic testing, and ongoing disease management.<\/p>\n<p>\nThe partnership with CUC America represents a significant milestone for Vascular Specialists as the practice continues to expand its clinical capabilities and geographic reach. Through this collaboration, Vascular Specialists will benefit from CUC America\u2019s operational resources, infrastructure support, and strategic growth expertise, enabling the physicians to remain focused on delivering high-quality patient care while accelerating long-term expansion.<\/p>\n<p>\n\u201cVascular Specialists has built an exceptional clinical platform with a strong reputation in vascular medicine,\u201d said <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fsamir-qureshi-aba3b05%2F&amp;esheet=54439715&amp;newsitemid=20260306796574&amp;lan=en-US&amp;anchor=Samir+Qureshi%2C+President+of+Viper+Partners&amp;index=3&amp;md5=e8f15f5887db9ed2d5bbaae93a084324\" rel=\"nofollow\" shape=\"rect\"><b>Samir Qureshi, President of Viper Partners<\/b><\/a>. \u201cThis partnership with CUC America positions the practice for continued growth while preserving the physician-led culture and commitment to patient outcomes that has defined the organization.\u201d<\/p>\n<p>\nCUC America partners with leading physician groups across the United States, providing capital, operational expertise, and infrastructure designed to support the growth of specialty healthcare platforms while maintaining clinical autonomy.<\/p>\n<p>\nThe transaction reflects continued momentum in physician practice partnerships, particularly in specialty medical fields where scaled infrastructure and operational support can enhance both patient access and clinical outcomes.<\/p>\n<p>\n<b>About Vascular Specialists<\/b><\/p>\n<p>\nVascular Specialists is a leading provider of comprehensive vascular care, offering advanced diagnostic and treatment services for a wide range of vascular conditions. The practice is committed to delivering high-quality, patient-centered care through innovative treatment approaches and experienced clinical leadership. Learn more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vascspecialists.org%2F&amp;esheet=54439715&amp;newsitemid=20260306796574&amp;lan=en-US&amp;anchor=www.vascspecialists.org&amp;index=4&amp;md5=bf9272e0a13546a528e1c3198551e38f\" rel=\"nofollow\" shape=\"rect\"><b>www.vascspecialists.org<\/b><\/a>.<\/p>\n<p>\n<b>About CUC America<\/b><\/p>\n<p>\nCUC America partners with physician-led healthcare organizations to support their growth and operational development. The organization provides strategic capital, infrastructure, and management support to enable medical practices to expand while maintaining clinical independence.<\/p>\n<p>\n<b>About Viper Partners<\/b><\/p>\n<p>\nViper Partners is a healthcare-focused advisory firm specializing in mergers and acquisitions and strategic partnerships. The firm works with physician groups, founders, and healthcare organizations to structure transactions that support long-term growth and value creation.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Transaction Contact:<\/b><\/p>\n<p>\n<b>Samir Qureshi<\/b><br \/><b>President, Viper Partners<\/b><br \/><b>Phone: <\/b>305-281-5259<br \/>\n<br \/><b>Email: <\/b><a target=\"_blank\" href=\"mailto:s&#97;&#109;&#105;&#114;&#64;&#118;&#105;&#112;&#101;&#114;&#x65;&#x71;&#x75;&#x69;&#x74;&#x79;&#x70;&#x61;&#x72;&#x74;&#x6e;&#x65;&#x72;&#x73;&#x2e;com\" rel=\"nofollow\" shape=\"rect\">&#115;&#x61;&#109;&#x69;&#114;&#x40;&#118;&#x69;&#112;&#x65;&#114;&#x65;q&#x75;i&#x74;y&#x70;a&#x72;t&#x6e;e&#114;&#x73;&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PALM BEACH GARDENS, Fla.&#8211;(BUSINESS WIRE)&#8211;#ClinicalExcellence&#8211;Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading healthcare services organization focused on supporting physician-led specialty platforms. Vascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62750","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PALM BEACH GARDENS, Fla.&#8211;(BUSINESS WIRE)&#8211;#ClinicalExcellence&#8211;Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading healthcare services organization focused on supporting physician-led specialty platforms. Vascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-06T15:06:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America\",\"datePublished\":\"2026-03-06T15:06:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/\"},\"wordCount\":428,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260306796574\\\/en\\\/2739254\\\/22\\\/VP_Logo_White.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/\",\"name\":\"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260306796574\\\/en\\\/2739254\\\/22\\\/VP_Logo_White.jpg\",\"datePublished\":\"2026-03-06T15:06:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260306796574\\\/en\\\/2739254\\\/22\\\/VP_Logo_White.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260306796574\\\/en\\\/2739254\\\/22\\\/VP_Logo_White.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/","og_locale":"en_US","og_type":"article","og_title":"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America - Pharma Trend","og_description":"PALM BEACH GARDENS, Fla.&#8211;(BUSINESS WIRE)&#8211;#ClinicalExcellence&#8211;Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading healthcare services organization focused on supporting physician-led specialty platforms. Vascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-06T15:06:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America","datePublished":"2026-03-06T15:06:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/"},"wordCount":428,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/","url":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/","name":"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg","datePublished":"2026-03-06T15:06:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260306796574\/en\/2739254\/22\/VP_Logo_White.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/viper-partners-advises-vascular-specialists-in-strategic-partnership-with-cuc-america\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Viper Partners Advises Vascular Specialists in Strategic Partnership with CUC America"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62750"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62750\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}